NAS:IART (USA) Also trade in: Germany

Integra Lifesciences Holdings Corp

$ 51.88 0 (0%)
Volume: 433,366 Avg Vol (1m): 450,090
Market Cap $: 4.43 Bil Enterprise Value $: 5.64 Bil
P/E (TTM): 54.04 P/B: 3.23
Earnings Power Value -12.58
Net Current Asset Value -11.43
Tangible Book -6.77
Projected FCF 21.28
Median P/S Value 30.83
Graham Number 0
Peter Lynch Value 8.61
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 5/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 0.12
Cash-To-Debt ranked lower than
93.94% of 330 companies
in the Medical Devices industry.
Industry Max: 504099, Med: 2.32, Min: -16.34
IART: 0.12
Ranked among companies with meaningful Cash-To-Debt only.
Cash-To-Debt range over the past 10 years
Min: 0.07, Med: 0.35, Max: 10000
Current: 0.12
0.07
10000
Equity-to-Asset 0.44
Equity-to-Asset ranked lower than
89.00% of 309 companies
in the Medical Devices industry.
Industry Max: 0.99, Med: 0.63, Min: -24.4
IART: 0.44
Ranked among companies with meaningful Equity-to-Asset only.
Equity-to-Asset range over the past 10 years
Min: 0.29, Med: 0.49, Max: 0.97
Current: 0.44
0.29
0.97
Debt-to-Equity 0.98
Debt-to-Equity ranked lower than
95.45% of 220 companies
in the Medical Devices industry.
Industry Max: 11.69, Med: 0.3, Min: 0.01
IART: 0.98
Ranked among companies with meaningful Debt-to-Equity only.
Debt-to-Equity range over the past 10 years
Min: 0.02, Med: 0.88, Max: 2.01
Current: 0.98
0.02
2.01
Debt-to-EBITDA 5.62
Debt-to-EBITDA ranked lower than
93.67% of 158 companies
in the Medical Devices industry.
Industry Max: 3384.46, Med: 1.98, Min: 0.02
IART: 5.62
Ranked among companies with meaningful Debt-to-EBITDA only.
Debt-to-EBITDA range over the past 10 years
Min: 2.83, Med: 5, Max: 13.6
Current: 5.62
2.83
13.6
Interest Coverage 1.99
Interest Coverage ranked lower than
96.70% of 212 companies
in the Medical Devices industry.
Industry Max: 10000, Med: 66.37, Min: 0.03
IART: 1.99
Ranked among companies with meaningful Interest Coverage only.
Interest Coverage range over the past 10 years
Min: 1.28, Med: 3.21, Max: 5.38
Current: 1.99
1.28
5.38
Piotroski F-Score 6
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.41
DISTRESS
GREY
SAFE
Beneish M-Score -2.54
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 5.09%
WACC 10.43%

Profitability & Growth : 7/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 7.98
Operating Margin ranked higher than
53.85% of 312 companies
in the Medical Devices industry.
Industry Max: 1148.46, Med: 1.96, Min: -47867.72
IART: 7.98
Ranked among companies with meaningful Operating Margin only.
Operating Margin range over the past 10 years
Min: 3.77, Med: 8.7, Max: 14.33
Current: 7.98
3.77
14.33
Net Margin % 5.60
Net Margin ranked higher than
62.82% of 312 companies
in the Medical Devices industry.
Industry Max: 15538.12, Med: 1.4, Min: -45900
IART: 5.6
Ranked among companies with meaningful Net Margin only.
Net Margin range over the past 10 years
Min: -3.02, Med: 4.62, Max: 8.97
Current: 5.6
-3.02
8.97
ROE % 6.37
ROE ranked higher than
64.80% of 304 companies
in the Medical Devices industry.
Industry Max: 51.97, Med: 0.95, Min: -2921.66
IART: 6.37
Ranked among companies with meaningful ROE only.
ROE range over the past 10 years
Min: -3.56, Med: 6.42, Max: 13.9
Current: 6.37
-3.56
13.9
ROA % 2.59
ROA ranked higher than
60.24% of 332 companies
in the Medical Devices industry.
Industry Max: 1204.95, Med: -0.26, Min: -2520.55
IART: 2.59
Ranked among companies with meaningful ROA only.
ROA range over the past 10 years
Min: -1.79, Med: 2.59, Max: 6.71
Current: 2.59
-1.79
6.71
ROC (Joel Greenblatt) % 19.35
ROC (Joel Greenblatt) ranked higher than
56.57% of 327 companies
in the Medical Devices industry.
Industry Max: 8175, Med: 3.87, Min: -323166.67
IART: 19.35
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
ROC (Joel Greenblatt) range over the past 10 years
Min: 8.29, Med: 17.62, Max: 32.36
Current: 19.35
8.29
32.36
3-Year Total Revenue Growth Rate 18.60
3-Year Revenue Growth Rate ranked higher than
60.24% of 254 companies
in the Medical Devices industry.
Industry Max: 300.7, Med: 4.3, Min: -100
IART: 12.3
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
3-Year Revenue Growth Rate range over the past 10 years
Min: -5.3, Med: 14.8, Max: 55
Current: 12.3
-5.3
55
3-Year Total EBITDA Growth Rate 17.60
3-Year EBITDA Growth Rate ranked lower than
61.64% of 232 companies
in the Medical Devices industry.
Industry Max: 109.5, Med: 7.5, Min: -344.2
IART: 11.4
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
3-Year EBITDA Growth Rate range over the past 10 years
Min: 0, Med: 8.8, Max: 39.7
Current: 11.4
0
39.7
3-Year EPS w/o NRI Growth Rate 93.10
3-Year EPS w/o NRI Growth Rate ranked higher than
60.09% of 223 companies
in the Medical Devices industry.
Industry Max: 241, Med: 7.8, Min: -413
IART: 93.1
Ranked among companies with meaningful 3-Year EPS w/o NRI Growth Rate only.
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: 4.1, Max: 93.1
Current: 93.1
0
93.1

» IART's 30-Y Financials

Financials (Next Earnings Date: 2019-07-25)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:IART

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Devices » Medical Devices    NAICS : 339112    SIC : 3841
Compare NYSE:GMED NAS:WMGI HKSE:01066 NAS:TNDM SZSE:300529 NYSE:PEN NAS:LIVN OCSE:AMBU B SZSE:002223 NAS:NUVA XSWX:TECN OCSE:OSSR TSE:6849 NAS:CNMD SZSE:300003 NYSE:ITGR TSE:3360 OCSE:GN NAS:PODD TSE:8086
Traded in other countries IL3.Germany
Address 311 Enterprise Drive, Plainsboro, NJ, USA, 08536
Integra Lifesciences Holdings Corp is a medical technology company that provides regenerative, specialty surgical, and orthopedic solutions to surgeons. The firm operates in two segments: specialty surgical solutions, and orthopedics and tissue technology. The specialty surgical solutions business contributes the majority of revenue. It sells surgical instruments for a variety of specialties, including products for dural repair, precision instruments, tissue ablation, and neuro-critical care. The orthopedics and tissue technology business sells soft-tissue repair and tissue-regeneration products and small-bone fixation and joint-replacement solutions. Integra generates the majority of its revenue in the United States.

Ratios

Current vs industry vs history
PE Ratio (TTM) 54.04
PE Ratio ranked lower than
82.22% of 180 companies
in the Medical Devices industry.
Industry Max: 8940, Med: 30.17, Min: 0.06
IART: 54.04
Ranked among companies with meaningful PE Ratio only.
PE Ratio range over the past 10 years
Min: 15.26, Med: 42.1, Max: 6446
Current: 54.04
15.26
6446
Forward PE Ratio 18.94
Forward P/E ranked higher than
59.62% of 52 companies
in the Medical Devices industry.
Industry Max: 454.55, Med: 25.06, Min: 3.33
IART: 18.94
Ranked among companies with meaningful Forward P/E only.
N/A
PE Ratio without NRI 54.04
PE without NRI ranked lower than
81.56% of 179 companies
in the Medical Devices industry.
Industry Max: 8940, Med: 30.17, Min: 0.06
IART: 54.04
Ranked among companies with meaningful PE without NRI only.
PE without NRI range over the past 10 years
Min: 15.26, Med: 40.63, Max: 506.24
Current: 54.04
15.26
506.24
Price-to-Owner-Earnings 40.14
Price-to-Owner-Earnings ranked lower than
80.77% of 104 companies
in the Medical Devices industry.
Industry Max: 10850, Med: 32.03, Min: 0.73
IART: 40.14
Ranked among companies with meaningful Price-to-Owner-Earnings only.
Price-to-Owner-Earnings range over the past 10 years
Min: 8.25, Med: 38.6, Max: 1344.69
Current: 40.14
8.25
1344.69
PB Ratio 3.23
PB Ratio ranked lower than
64.19% of 310 companies
in the Medical Devices industry.
Industry Max: 1180, Med: 3.06, Min: 0.07
IART: 3.23
Ranked among companies with meaningful PB Ratio only.
PB Ratio range over the past 10 years
Min: 1.21, Med: 2.36, Max: 5.11
Current: 3.23
1.21
5.11
PS Ratio 3.04
PS Ratio ranked lower than
53.74% of 294 companies
in the Medical Devices industry.
Industry Max: 1136.36, Med: 3.15, Min: 0.05
IART: 3.04
Ranked among companies with meaningful PS Ratio only.
PS Ratio range over the past 10 years
Min: 0.79, Med: 1.79, Max: 4.19
Current: 3.04
0.79
4.19
Price-to-Free-Cash-Flow 40.85
Price-to-Free-Cash-Flow ranked lower than
81.31% of 107 companies
in the Medical Devices industry.
Industry Max: 3239, Med: 26.44, Min: 5.07
IART: 40.85
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
Price-to-Free-Cash-Flow range over the past 10 years
Min: 6.16, Med: 30.08, Max: 122.19
Current: 40.85
6.16
122.19
Price-to-Operating-Cash-Flow 23.70
Price-to-Operating-Cash-Flow ranked lower than
74.80% of 127 companies
in the Medical Devices industry.
Industry Max: 1586.78, Med: 20.01, Min: 3.03
IART: 23.7
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 5.38, Med: 19.72, Max: 40.49
Current: 23.7
5.38
40.49
EV-to-EBIT 42.66
EV-to-EBIT ranked lower than
95.40% of 174 companies
in the Medical Devices industry.
Industry Max: 18456.56, Med: 24.76, Min: 0.63
IART: 42.66
Ranked among companies with meaningful EV-to-EBIT only.
EV-to-EBIT range over the past 10 years
Min: -149.8, Med: 29.05, Max: 128.6
Current: 42.66
-149.8
128.6
EV-to-EBITDA 23.26
EV-to-EBITDA ranked lower than
84.57% of 188 companies
in the Medical Devices industry.
Industry Max: 18456.56, Med: 18.14, Min: 0.62
IART: 23.26
Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA range over the past 10 years
Min: 8.1, Med: 19, Max: 44.1
Current: 23.26
8.1
44.1
EV-to-Revenue 3.86
EV-to-Revenue ranked lower than
62.78% of 309 companies
in the Medical Devices industry.
Industry Max: 17078.6, Med: 3.73, Min: 0.05
IART: 3.86
Ranked among companies with meaningful EV-to-Revenue only.
EV-to-Revenue range over the past 10 years
Min: 1.3, Med: 2.5, Max: 5.3
Current: 3.86
1.3
5.3
PEG Ratio 4.05
PEG Ratio ranked lower than
94.81% of 77 companies
in the Medical Devices industry.
Industry Max: 804, Med: 2.53, Min: 0.14
IART: 4.05
Ranked among companies with meaningful PEG Ratio only.
PEG Ratio range over the past 10 years
Min: 0.56, Med: 3.69, Max: 2812.44
Current: 4.05
0.56
2812.44
Shiller PE Ratio 79.88
Shiller PE Ratio ranked lower than
82.76% of 58 companies
in the Medical Devices industry.
Industry Max: 636.22, Med: 49.95, Min: 2.03
IART: 79.88
Ranked among companies with meaningful Shiller PE Ratio only.
Shiller PE Ratio range over the past 10 years
Min: 17.3, Med: 39.14, Max: 113.95
Current: 79.88
17.3
113.95
Current Ratio 2.86
Current Ratio ranked lower than
54.32% of 324 companies
in the Medical Devices industry.
Industry Max: 563.8, Med: 2.71, Min: 0.03
IART: 2.86
Ranked among companies with meaningful Current Ratio only.
Current Ratio range over the past 10 years
Min: 0.81, Med: 4.2, Max: 20.74
Current: 2.86
0.81
20.74
Quick Ratio 1.86
Quick Ratio ranked lower than
64.20% of 324 companies
in the Medical Devices industry.
Industry Max: 563.8, Med: 2.03, Min: 0.02
IART: 1.86
Ranked among companies with meaningful Quick Ratio only.
Quick Ratio range over the past 10 years
Min: 0.46, Med: 2.63, Max: 19.26
Current: 1.86
0.46
19.26
Days Inventory 188.89
Days Inventory ranked lower than
70.07% of 294 companies
in the Medical Devices industry.
Industry Max: 990.33, Med: 143.61, Min: 0.63
IART: 188.89
Ranked among companies with meaningful Days Inventory only.
Days Inventory range over the past 10 years
Min: 184.16, Med: 214.3, Max: 247.25
Current: 188.89
184.16
247.25
Days Sales Outstanding 69.06
Days Sales Outstanding ranked lower than
60.14% of 276 companies
in the Medical Devices industry.
Industry Max: 907.73, Med: 69.21, Min: 0.13
IART: 69.06
Ranked among companies with meaningful Days Sales Outstanding only.
Days Sales Outstanding range over the past 10 years
Min: 50.48, Med: 54.95, Max: 77.35
Current: 69.06
50.48
77.35
Days Payable 65.99
Days Payable ranked higher than
61.30% of 261 companies
in the Medical Devices industry.
Industry Max: 912.5, Med: 58.34, Min: 1
IART: 65.99
Ranked among companies with meaningful Days Payable only.
Days Payable range over the past 10 years
Min: 30.38, Med: 38.34, Max: 78.75
Current: 65.99
30.38
78.75

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -4.40
3-Year Share Buyback Rate ranked lower than
52.87% of 244 companies
in the Medical Devices industry.
Industry Max: 19.2, Med: -5.7, Min: -1393.3
IART: -4.4
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
3-Year Share Buyback Rate range over the past 10 years
Min: -18.8, Med: -4.2, Max: 3.1
Current: -4.4
-18.8
3.1

Valuation & Return

Current vs industry vs history
Price-to-Projected-FCF 2.44
Price-to-Intrinsic-Value-Projected-FCF ranked lower than
71.90% of 121 companies
in the Medical Devices industry.
Industry Max: 89.64, Med: 2.44, Min: 0.43
IART: 2.44
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 0.62, Med: 1.85, Max: 9.6
Current: 2.44
0.62
9.6
Price-to-Median-PS-Value 1.68
Price-to-Median-PS-Value ranked lower than
87.34% of 237 companies
in the Medical Devices industry.
Industry Max: 20.13, Med: 1.02, Min: 0.02
IART: 1.68
Ranked among companies with meaningful Price-to-Median-PS-Value only.
Price-to-Median-PS-Value range over the past 10 years
Min: 0.54, Med: 1.81, Max: 10.73
Current: 1.68
0.54
10.73
Price-to-Peter-Lynch-Fair-Value 6.03
Price-to-Peter-Lynch-Fair-Value ranked lower than
91.49% of 47 companies
in the Medical Devices industry.
Industry Max: 26.18, Med: 2.05, Min: 0.43
IART: 6.03
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
Price-to-Peter-Lynch-Fair-Value range over the past 10 years
Min: 0.35, Med: 1.38, Max: 9.47
Current: 6.03
0.35
9.47
Earnings Yield (Joel Greenblatt) % 2.35
Earnings Yield (Greenblatt) ranked higher than
50.30% of 332 companies
in the Medical Devices industry.
Industry Max: 158.73, Med: 0.74, Min: -2500
IART: 2.35
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
Earnings Yield (Greenblatt) range over the past 10 years
Min: -0.8, Med: 3.2, Max: 8.6
Current: 2.35
-0.8
8.6
Forward Rate of Return (Yacktman) % 10.87
Forward Rate of Return ranked higher than
59.20% of 125 companies
in the Medical Devices industry.
Industry Max: 78.28, Med: 6.6, Min: -76.71
IART: 10.87
Ranked among companies with meaningful Forward Rate of Return only.
Forward Rate of Return range over the past 10 years
Min: -8.8, Med: 12.4, Max: 28.5
Current: 10.87
-8.8
28.5

More Statistics

Revenue (TTM) (Mil) $ 1,475.05
EPS (TTM) $ 0.96
Beta 1.19
Volatility % 35.25
52-Week Range $ 42.14 - 67.5
Shares Outstanding (Mil) 85.48

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 6
Positive ROA Y
Positive CFROA Y
Higher ROA yoy N
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy Y
Less Shares Outstanding yoy N
Higher Gross Margin yoy Y
Higher Asset Turnover yoy N